Profiel
Yuriy Rubin is currently a Director at PharmaIN Corp.
He was previously a Chief Financial Officer & VP-Business Development at Irkutskaya Neftyanaya Kompaniya OOO.
Actieve functies van Yuriy Rubin
| Bedrijven | Functie | Begin |
|---|---|---|
PharmaIN Corp.
 PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Yuriy Rubin
| Bedrijven | Functie | Einde |
|---|---|---|
Irkutskaya Neftyanaya Kompaniya OOO
 Irkutskaya Neftyanaya Kompaniya OOO Integrated OilEnergy Minerals Irkutskaya Neftyanaya Kompaniya OOO produces oil and gas. It also engages in geological study, exploration, drilling, and production of crude oil, condensate, and natural gas. The company was founded by Mikhail Buynov and Nikolay Buynov on November 27, 2000 and is headquartered in Irkutsk, Russia Federation. | Financieel Directeur/CFO | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Irkutskaya Neftyanaya Kompaniya OOO
Irkutskaya Neftyanaya Kompaniya OOO Integrated OilEnergy Minerals Irkutskaya Neftyanaya Kompaniya OOO produces oil and gas. It also engages in geological study, exploration, drilling, and production of crude oil, condensate, and natural gas. The company was founded by Mikhail Buynov and Nikolay Buynov on November 27, 2000 and is headquartered in Irkutsk, Russia Federation. | Energy Minerals |
PharmaIN Corp.
PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | Health Technology |
